Saturday, May 18, 2002

ASCO 2002 OncoLink Booth at ASCO 2002
James Metz, MD, Editor-in-Chief and Maggie Hampshire, RN, BSN, OCN, Managing Editor, at the OncoLink Booth


Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from INT 0114 Caelyx (Ca) And Carboplatin (Pa) In Patients With Advanced Ovarian Cancer In Late Relapse (> 6 Months) (AOCLR): A GINECO Phase II Trial Cancer Patients in US Nursing Homes: Quality of End of Life Care Effect Of Nerve Stimulation Therapy On Chemotherapy Induced Emesis (Cie): A Randomized, Placebo Controlled Trial Evaluating The Efficacy Of The Reliefband (Rb) Device Final Report of the Efficacy and Safety of the Anti-Epidermal Growth Factor Antibody, Cetuximab (IMC-C225), in Combination with Cisplatin in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) Refractory to Cisplatin Containing-Ch Issues in the Access of Promising New Cancer Agents Parenteral Opioid Rotation in Advanced Cancer Phase I Study of Docetaxel (D), Cisplatin (P), and Concomitant Boost Radiation for Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck (SCHN) Phase III Quality Of Life (QOL) Study: Reduction In Hyposalivation Does Not Improve Qol For Head And Neck (H&N) Cancer Patients Post Radiation Therapy (P-Rt). Rtog 9709 Prostate Cancer Radiation Dose Response: Final Planned Analysis Of A Phase III Randomized Trial Prostate Cancer Radiation Dose Response: Final Planned Analysis Of A Phase III Randomized Trial Tumor microsatellite instability (MSI) and the benefit of 5-FU based chemotherapy in stage II & stage III colon cancer: a pooled molecular reanalysis of randomized chemotherapy trials Use of Low-dose Fractionated Radiation (LDFRT) as a Chemosensitizer of Neoadjuvant Paclitaxel (P) and Carboplatin (CBCDA) for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) - Results of a New Treatment Paradigm Weekly Erythropoietin For Patients With Chemotherapy Induced Anemia: A Randomized, Placebo-Controlled Trial In The North Central Cancer Treatment Group Weekly taxol (T) and carboplatin (P) as first-line therapy in advanced ovarian cancer (AOC): a phase II study

Keywords

Click on any of these terms for more related articles

Blogs

Don't Assume You Understand
by Bob Riter
July 29, 2015